Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-15-011969
Filing Date
2015-03-16
Accepted
2015-03-16 16:26:50
Documents
17
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC. 10-K 12-31-2014 form10k.htm 10-K 1390421
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 9441
3 EXHIBIT 10.18 ex10_18.htm EX-10.18 262484
4 EXHIBIT 23.1 ex23_1.htm EX-23.1 2688
5 EXHIBIT 24.1 ex24_1.htm EX-24.1 27492
6 EXHIBIT 31.1 ex31_1.htm EX-31.1 12073
7 EXHIBIT 31.2 ex31_2.htm EX-31.2 11953
8 EXHIBIT 32.1 ex32_1.htm EX-32.1 7314
9 EXHIBIT 32.2 ex32_2.htm EX-32.2 7282
16 image0.jpg GRAPHIC 122374
17 image00001.jpg GRAPHIC 3902
  Complete submission text file 0001140361-15-011969.txt   12196715

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT rnn-20141231.xml EX-101.INS 2215431
11 XBRL TAXONOMY EXTENSION SCHEMA rnn-20141231.xsd EX-101.SCH 69333
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20141231_cal.xml EX-101.CAL 53884
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20141231_def.xml EX-101.DEF 167854
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20141231_lab.xml EX-101.LAB 436201
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20141231_pre.xml EX-101.PRE 370482
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34079 | Film No.: 15703250
SIC: 2834 Pharmaceutical Preparations